TOPICAL INTERFERON ALPHA-2b GMP PROCESS DEVELOPMENT, SCALE UP AND CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND CONTRACT PHARMACEUTICALS LIMITED NIAGARA April _3__, 2008 CONFIDENTIAL TREATMENT REQUESTEDGMP Manufacturing Agreement • February 5th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 5th, 2009 Company Industry JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
TOPICAL INTERFERON ALPHA-2b GMP PROCESS DEVELOPMENT, SCALE UP AND CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND CONTRACT PHARMACEUTICALS LIMITED NIAGARA April _3__, 2008 CONFIDENTIAL TREATMENT REQUESTEDGMP Manufacturing Agreement • February 4th, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 4th, 2009 Company Industry JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
TOPICAL INTERFERON ALPHA-2b GMP PROCESS DEVELOPMENT, SCALE UP AND CLINICAL SUPPLIES MANUFACTURING AGREEMENT BETWEEN HELIX BIOPHARMA CORP. AND CONTRACT PHARMACEUTICALS LIMITED NIAGARA April _3__, 2008 CONFIDENTIAL TREATMENT REQUESTEDGMP Manufacturing Agreement • November 25th, 2008 • Helix BioPharma Corp • Ontario
Contract Type FiledNovember 25th, 2008 Company JurisdictionINFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.